Farshid Hasanzadeh
Overview
Explore the profile of Farshid Hasanzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Afsharzadeh M, Varshosaz J, Mirian M, Hasanzadeh F
Invest New Drugs
. 2023 Dec;
42(1):89-105.
PMID: 38127209
This study aimed to prepare SLC7A5 transporters targeted liposomes of Ribociclib (RB) by stear(o)yl conjugation of Phe, Asp, Glu amino acids to liposomes as targeting moieties. The liposomes were optimized...
2.
Alimardan Z, Abbasi M, Hasanzadeh F, Aghaei M, Khodarahmi G, Kashfi K
Biochem Pharmacol
. 2023 Mar;
211:115505.
PMID: 36931349
Heat shock proteins (Hsp) and FoxM1 have significant roles in carcinogenesis. According to their relative molecular weight, Hsps are divided into Hsp110, Hsp90, Hsp70, Hsp60, Hsp40, and small Hsps. Hsp70...
3.
Identification of new small molecules as dual FoxM1 and Hsp70 inhibitors using computational methods
Alimardan Z, Abbasi M, Khodarahmi G, Kashfi K, Hasanzadeh F, Mahmud A
Res Pharm Sci
. 2023 Jan;
17(6):635-656.
PMID: 36704430
Background And Purpose: FoxM1 and Hsp70 proteins are highly expressed in many cancers. Thus, their inhibition serves as Bonafede targets in cancer treatment. Experimental Approach: FDI-6, an inhibitor of FoxM1,...
4.
Akbari V, Rezazadeh M, Hanaie N, Hasanzadeh F
Biotechnol Appl Biochem
. 2021 Apr;
69(3):1047-1057.
PMID: 33878804
Localized and sustained delivery of DNA using biomaterial scaffolds would increase the applicability of gene therapy in cancer treatment and tissue engineering. The most promising approach is the application of...
5.
Fassihi A, Hasanzadeh F, Movahedian Attar A, Saghaie L, Mohammadpour M
Res Pharm Sci
. 2021 Apr;
15(6):515-528.
PMID: 33828595
Background And Purpose: Reactive oxygen species (ROSs) are continuously produced as byproducts of cell metabolism. Free radicals are an unstable form of ROSs with the tendency to react readily with...
6.
Kazemi M, Emami J, Hasanzadeh F, Minaiyan M, Mirian M, Lavasanifar A, et al.
Recent Pat Anticancer Drug Discov
. 2020 Oct;
15(4):341-359.
PMID: 33023456
Background: The development of biocompatible tumor-targeting delivery systems for anticancer agents is essential for efficacious cancer chemotherapy. Nanoparticles, as drug delivery cargoes for cancer therapy, are rapidly improving to overcome...
7.
Kazemi M, Emami J, Hasanzadeh F, Minaiyan M, Mirian M, Lavasanifar A
Res Pharm Sci
. 2020 Mar;
15(1):1-13.
PMID: 32180812
Background And Purpose: A simple, rapid, and sensitive reversed-phase high performance liquid chromatography (RP-HPLC) method based on liquid-liquid extraction was developed and validated for determination of docetaxel (DTX) in plasma...
8.
Emami J, Kazemi M, Hasanzadeh F, Minaiyan M, Mirian M, Lavasanifar A
Pharm Dev Technol
. 2020 Jan;
25(4):492-509.
PMID: 31903817
In this study, pH-triggered polymeric micelle comprising α-tocopherol (TOC) and heparin (HEP) was developed and loaded with docetaxel (DTX). The amphiphilic copolymer was synthesized by grafting TOC onto HEP backbone...
9.
Rezazadeh M, Davatsaz Z, Emami J, Hasanzadeh F, Jahanian-Najafabadi A
J Pharm Pharm Sci
. 2018 Oct;
21(1s):200s-214s.
PMID: 30321135
Purpose: Local delivery of chemotherapeutic drugs to the lungs offers many advantages for lung cancer treatment compared to conventional systemic chemotherapy. In the present study, novel mixed polymeric micelles based...
10.
Emami J, Maghzi P, Hasanzadeh F, Sadeghi H, Mirian M, Rostami M
Pharm Dev Technol
. 2017 Jun;
23(1):41-54.
PMID: 28608760
To develop an effective therapeutic treatment, the potential of poly (lactic-co-glycolic acid)-polyethylene glycol-retinoic acid (PLGA-PEG-RA) polymeric micelles for targeted delivery of irinotecan to hepatocellular carcinoma (HepG2) and colorectal cancer cell...